Welcome!

News Feed Item

Injectable Drug Delivery - Advances in Drug Delivery, Injection Devices and Technology (Conference, London)

DUBLIN, Mar. 20, 2014 /PRNewswire/ --

Research and Markets

(

http://www.researchandmarkets.com/research/sq2qm5/injectable_drug

) has announced the addition of the

"Injectable Drug Delivery - Advances in Drug Delivery, Injection Devices and Technology (Conference, London)"

conference to their offering.



(Logo: http://photos.prnewswire.com/prnh/20130307/600769)

The Injectable Drug Delivery Conference will be held on the 26th & 27th March 2014 at Le Meridien Hotel, Piccadilly, London



KEY TOPICS TO INCLUDE:


- Market trends


- Human factors and useability


- Fluid dynamics - modelling the realities of injection performance


- Delivery of high viscosity drugs


- Case study presentation on devices in development


- Latest self injection trends


- Development of a parenteral device


- Delivery of high volumes


- Compliance modelling and parenteral drug delivery


- The insulet drug delivery system



DATES:



26 & 27 March 2014



TIMES:



Day One: 26 March 2013


Start times: 9.30 Finish 17.45



Drinks Reception Followed by Dinner 19.30



Day Two: 27 March 2013


Start times: 9.00 Finish 16.15



VENUE FOR CONFERENCE AND DINNER:



Le Meridien Hotel, Piccadilly, London



NOTE: Please note that there is a Pre-conference seminar on 25th March on 'Prefilled Syringes - Advances in Manufacture' and also a Post Conference Workshop on 28th March on 'Human Factors and Usability Engineering in the development of drug delivery products'.



Events may be cancelled due to commercial or organisational reasons. In this case Research and Markets will refund all registration fees which have already been paid. Research and Markets will not refund any charges arising from the participant having to cancel or re-book transportation or accommodation which he or she has arranged



Key Topics Covered:



INJECTABLE DRUG DELIVERY DAY ONE - 26 March 2013



09.30 - Chairman's Welcome and Introduction


Dr Gregory Berman,


Head of Innovation and Technology Management Group, Sagentia, UK



09.40 - Key Note Address: Market Trends



- High concentration formulations



- Larger doses, less frequent injections


Mathias Romacker, Drug Delivery Devices and Business Development, Amgen, USA



10.20 - Human Factors and Useability



- Ethonographic research on atuoinjector use for chronic conditions



- Relationship between a disease and its therapy - emotional and functional levels



- How this affects device selection


Mathew Young, CEO, Oval Medical Technologies Ltd, UK



11.00 - Discussion followed by Coffee



11.30 - Fluid Dynamics - Modelling the Realities of Injection Performance



- Mathematical modelling enables the opportunities and challenges of a range of device types to be explored early



- The implications of such characteristics as viscosity, dose volume and injection frequency are inseparable from the choice of delivery device



- Unfortunately, early consideration of the delivery device does not always take place. Opportunities can thus be lost and problems created which are costly and difficult to solve later



- Mathematical modelling techniques, applied properly, improve understanding of the issues concerned and enable better and earlier decisions to be taken



- Better informed decisions and better appreciations of the design options in turn support device designs which are better for the end user



- Early understanding of device issues supports and enables robust designs and capable manufacture



- Early understanding can shorten development timescales, in turn making earlier approval and earlier revenues possible


Andy Fry, Founder, Team Consulting, UK



12.10 - Delivery of High Viscosity Drugs



- Device formats



- Overcoming the challenges


Speaker, (invited)



12.50 - Discussion followed by Lunch



14.10 - Mixing Technologies for Reconstitution Devices



- Market Needs - Industry drivers and demands for these types of devices



- Latest mixing technologies



- Comparison of Lyophilised and Spray drying technologies



- Technical challenges with these types of devices


Tom Bailey, Managing Director, 3PInnovation, UK



14.50 - Device Case Study


Ian Anderson, Innovation Director, Bespak UK (invited)



15.30 - Discussion followed by Tea



16.10 - Latest Self Injection Trends



- General market trends



- Trends for biologics



- Trends for generics



- Pre-configured devices



- Future outlook


Mats Persson, Managing Director, SHL Group, Sweden



16.50 - Innovation in Primary Container Materials



- Trends for user requirements intended for self injection



- Material technology options and selection criteria



- Integration of Quality by Design for components



- Platform approach for lifecycle management


Tibor Hlobik, West Pharmaceutical Services



17.30 - Discussion



17.45 - End of Day One



19.30 - Drinks Reception Followed by Dinner at Le Meridien Hotel, London



INJECTABLE DRUG DELIVERY DAY TWO - 27 March 2013



09.00 - Review of Day One


Dr Gregory Berman,


Head of Innovation and Technology Management Group, Sagentia, UK



09.10 - What Does Pharma Want From its Drug Delivery Suppliers


Nick Bowman, Senior Director, Head of Devices COE, Pfizer, UK



09.50 - Pump Technology Case Study


Jonathan Rigby, President & CEO, SteadyMed Therapeutics Inc, USA, (invited)



10.30 - Discussion followed by Coffee



11.10 - Compliance Monitoring and Parenteral Drug Delivery



- Why is the industry suddenly talking about compliance and adherence monitoring (clinical trials and commercial applications)



- Advances in wireless communications enabling intelligent compliance monitoring



- The widespread availability of smart devices and their use in compliance monitoring, adherence and patient education



- Use of smartphone / smart devices apps for providing real-time information display and the potential for two way communications with the patient



- Regulatory issues associated with connected health systems and smartphone apps



- Using the cloud to store and disseminate data securely


Mark Tuckwell, Senior Consultant, Connected Health Systems,


Sagentia, UK



11.50 - Wireless Communication and Electronics for Compliance Monitoring



- Patient therapy compliance continues to be one of the biggest challenges in health systems



- 50% of all patients do not complete required treatment



- Reasons for the high rate of non-compliance



- Opportunities for medical manufacturers to offer innovative solutions



- Electronic compliance aids open interesting possibilities to remind, monitor and track patients' behavior, as well as to share vital therapy information with healthcare providers



- Key technologies that facilitate compliance, ranging from low-cost disposable electronics for dose counts and logs to a complete cloud-based system for monitoring compliance


Lior Shtram, Director, Design & Engineering, Flextronics Medical, Israel



12.30 - Discussion followed by Lunch



14.00 - Update on Regulations and Standards


Lee Leichter, President P/L Medical, USA



14.40 - The Insulet Drug Delivery System



Consists of two components


- Drug Delivery Pod


- Drug Delivery Manager



A Programmable, body worn, disposable, subcutaneous infusion pump



- Delivers up to 2ml of drug product over a three day period


- Delivery rate from 0.5 to 300 µl/hr


- Automated catheter insertion


- Waterproof (IPX8 25 feet for up to 60 minutes)



Provides the HCP and user maximum control, versatility, comfort and safety, while overcoming the numerous drawbacks of conventional infusion pump systems


Kevin Schmid, Vice President, Business Development & Advanced Technology Insulet Corporation, USA



15.20 - The Rise of the Bolus Injector



The changing needs of patients and new drugs are driving the growth of a new class of injection device: the large volume' or bolus' injector. This presentation will report the findings of a new research project run in collaboration with the Judge Business School, covering:



- The changing needs of patients and new drugs



- Could autoinjectors and infusion pumps meet the needs?



- Bolus injectors: a new class of injection device



- Example devices



- What to expect from the draft standard ISO 11608-6' on bolus injectors.


Tom Oakley, Director of Drug Delivery Device Development, Springboard, UK



16.00 - Discussion and Chairman's Closing Remarks



16.15 - End of Conference and Tea




For more information visit

http://www.researchandmarkets.com/research/sq2qm5/injectable_drug



Media Contact:

Laura Wood , +353-1-481-1716, [email protected]


SOURCE Research and Markets

More Stories By PR Newswire

Copyright © 2007 PR Newswire. All rights reserved. Republication or redistribution of PRNewswire content is expressly prohibited without the prior written consent of PRNewswire. PRNewswire shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.

Latest Stories
Enterprise architects are increasingly adopting multi-cloud strategies as they seek to utilize existing data center assets, leverage the advantages of cloud computing and avoid cloud vendor lock-in. This requires a globally aware traffic management strategy that can monitor infrastructure health across data centers and end-user experience globally, while responding to control changes and system specification at the speed of today’s DevOps teams. In his session at 20th Cloud Expo, Josh Gray, Chie...
Learn how to solve the problem of keeping files in sync between multiple Docker containers. In his session at 16th Cloud Expo, Aaron Brongersma, Senior Infrastructure Engineer at Modulus, discussed using rsync, GlusterFS, EBS and Bit Torrent Sync. He broke down the tools that are needed to help create a seamless user experience. In the end, can we have an environment where we can easily move Docker containers, servers, and volumes without impacting our applications? He shared his results so yo...
Creating replica copies to tolerate a certain number of failures is easy, but very expensive at cloud-scale. Conventional RAID has lower overhead, but it is limited in the number of failures it can tolerate. And the management is like herding cats (overseeing capacity, rebuilds, migrations, and degraded performance). In his general session at 18th Cloud Expo, Scott Cleland, Senior Director of Product Marketing for the HGST Cloud Infrastructure Business Unit, discussed how a new approach is neces...
"This week we're really focusing on scalability, asset preservation and how do you back up to the cloud and in the cloud with object storage, which is really a new way of attacking dealing with your file, your blocked data, where you put it and how you access it," stated Jeff Greenwald, Senior Director of Market Development at HGST, in this SYS-CON.tv interview at 18th Cloud Expo, held June 7-9, 2016, at the Javits Center in New York City, NY.
Businesses and business units of all sizes can benefit from cloud computing, but many don't want the cost, performance and security concerns of public cloud nor the complexity of building their own private clouds. Today, some cloud vendors are using artificial intelligence (AI) to simplify cloud deployment and management. In his session at 20th Cloud Expo, Ajay Gulati, Co-founder and CEO of ZeroStack, discussed how AI can simplify cloud operations. He covered the following topics: why cloud mana...
FinTechs use the cloud to operate at the speed and scale of digital financial activity, but are often hindered by the complexity of managing security and compliance in the cloud. In his session at 20th Cloud Expo, Sesh Murthy, co-founder and CTO of Cloud Raxak, showed how proactive and automated cloud security enables FinTechs to leverage the cloud to achieve their business goals. Through business-driven cloud security, FinTechs can speed time-to-market, diminish risk and costs, maintain continu...
Docker containers have brought great opportunities to shorten the deployment process through continuous integration and the delivery of applications and microservices. This applies equally to enterprise data centers as well as the cloud. In his session at 20th Cloud Expo, Jari Kolehmainen, founder and CTO of Kontena, discussed solutions and benefits of a deeply integrated deployment pipeline using technologies such as container management platforms, Docker containers, and the drone.io Cl tool. H...
Everything run by electricity will eventually be connected to the Internet. Get ahead of the Internet of Things revolution. In his session at @ThingsExpo, Akvelon expert and IoT industry leader Sergey Grebnov provided an educational dive into the world of managing your home, workplace and all the devices they contain with the power of machine-based AI and intelligent Bot services for a completely streamlined experience.
Kubernetes is a new and revolutionary open-sourced system for managing containers across multiple hosts in a cluster. Ansible is a simple IT automation tool for just about any requirement for reproducible environments. In his session at @DevOpsSummit at 18th Cloud Expo, Patrick Galbraith, a principal engineer at HPE, discussed how to build a fully functional Kubernetes cluster on a number of virtual machines or bare-metal hosts. Also included will be a brief demonstration of running a Galera MyS...
It is of utmost importance for the future success of WebRTC to ensure that interoperability is operational between web browsers and any WebRTC-compliant client. To be guaranteed as operational and effective, interoperability must be tested extensively by establishing WebRTC data and media connections between different web browsers running on different devices and operating systems. In his session at WebRTC Summit at @ThingsExpo, Dr. Alex Gouaillard, CEO and Founder of CoSMo Software, presented ...
Enterprises are universally struggling to understand where the new tools and methodologies of DevOps fit into their organizations, and are universally making the same mistakes. These mistakes are not unavoidable, and in fact, avoiding them gifts an organization with sustained competitive advantage, just like it did for Japanese Manufacturing Post WWII.
DXWorldEXPO LLC, the producer of the world's most influential technology conferences and trade shows has announced the 22nd International CloudEXPO | DXWorldEXPO "Early Bird Registration" is now open. Register for Full Conference "Gold Pass" ▸ Here (Expo Hall ▸ Here)
In his session at @DevOpsSummit at 20th Cloud Expo, Kelly Looney, director of DevOps consulting for Skytap, showed how an incremental approach to introducing containers into complex, distributed applications results in modernization with less risk and more reward. He also shared the story of how Skytap used Docker to get out of the business of managing infrastructure, and into the business of delivering innovation and business value. Attendees learned how up-front planning allows for a clean sep...
Amazon started as an online bookseller 20 years ago. Since then, it has evolved into a technology juggernaut that has disrupted multiple markets and industries and touches many aspects of our lives. It is a relentless technology and business model innovator driving disruption throughout numerous ecosystems. Amazon’s AWS revenues alone are approaching $16B a year making it one of the largest IT companies in the world. With dominant offerings in Cloud, IoT, eCommerce, Big Data, AI, Digital Assista...
"Our strategy is to focus on the hyperscale providers - AWS, Azure, and Google. Over the last year we saw that a lot of developers need to learn how to do their job in the cloud and we see this DevOps movement that we are catering to with our content," stated Alessandro Fasan, Head of Global Sales at Cloud Academy, in this SYS-CON.tv interview at 20th Cloud Expo, held June 6-8, 2017, at the Javits Center in New York City, NY.